Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors (Q28575168)

2

1 reference

31 January 2017

M. Pangallo

3

1 reference

31 January 2017

D. Franceschini

4

1 reference

31 January 2017

S. D. Skaper

5

1 reference

31 January 2017

P. J. L. M. Strijbos

Mechanism of activation and function of protein kinase B.

6

1 reference

31 January 2017

1 October 2003

1 reference

31 January 2017

1 reference

31 January 2017

45

1 reference

31 January 2017

623–636

1 reference

31 January 2017

5

1 reference

31 January 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

The role of corticotropin-releasing factor in depression and anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Cellular localization of corticotropin releasing factor receptors in the adult mouse cerebellum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Corticotrophin-releasing factor receptors: from molecular biology to drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Specificity and mechanism of action of some commonly used protein kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Cloning and characterization of human urocortin [published erratum appears in Endocrinoogy 1996 Sep;137(9):3896]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Regulation of neuronal survival by the serine-threonine protein kinase Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

The role of depolarization in the survival and differentiation of cerebellar granule cells in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Nerve growth factor withdrawal induces the apoptotic death of developing septal cholinergic neurons in vitro: protection by cyclic AMP analogue and high potassium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: prevention of cell death by dibutyryl cyclic AMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Decrease in cerebellin and corticotropin-releasing hormone in the cerebellum of olivopontocerebellar atrophy and Shy-Drager syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Alzheimer's disease: genes, proteins, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Characterisation using microphysiometry of CRF receptor pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Cerebrospinal fluid corticotropin-releasing hormone in neurodegenerative diseases: reduction in spinocerebellar degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Activation of p44 and p42 MAP kinases is not essential for the survival of rat sympathetic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900211-9

10.1016/S0028-3908(03)00211-9

7 January 2021

Identifiers

DOI

0 references

Fatcat ID

release_ouj7pq6whnb4rfq5rpb6ypvh4q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ouj7pq6whnb4rfq5rpb6ypvh4q